The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-3883
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer ; day:22 ; month:11 ; year:2020 ; pages:1-6
Journal of applied genetics ; (22.11.2020), 1-6
- Creator
-
Mika, Justyna
Łabaj, Wojciech
Chekan, Mykola
Abramowicz, Agata
Pietrowska, Monika
Polanski, Andrzej
Widłak, Piotr
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13353-020-00594-0
- URN
-
urn:nbn:de:101:1-2021010119550514645668
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mika, Justyna
- Łabaj, Wojciech
- Chekan, Mykola
- Abramowicz, Agata
- Pietrowska, Monika
- Polanski, Andrzej
- Widłak, Piotr
- SpringerLink (Online service)
Other Objects (12)
Anaplastic thyroid cancer : How far can we go?
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Recent advances in the management of anaplastic thyroid cancer
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy
Anaplastic thyroid cancer : How far can we go?
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Recent advances in the management of anaplastic thyroid cancer
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy
Anaplastic thyroid cancer : How far can we go?
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Recent advances in the management of anaplastic thyroid cancer
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics